235 related articles for article (PubMed ID: 10644367)
1. A role for SKIP in EBNA2 activation of CBF1-repressed promoters.
Zhou S; Fujimuro M; Hsieh JJ; Chen L; Hayward SD
J Virol; 2000 Feb; 74(4):1939-47. PubMed ID: 10644367
[TBL] [Abstract][Full Text] [Related]
2. SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function.
Zhou S; Fujimuro M; Hsieh JJ; Chen L; Miyamoto A; Weinmaster G; Hayward SD
Mol Cell Biol; 2000 Apr; 20(7):2400-10. PubMed ID: 10713164
[TBL] [Abstract][Full Text] [Related]
3. Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex.
Zhou S; Hayward SD
Mol Cell Biol; 2001 Sep; 21(18):6222-32. PubMed ID: 11509665
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus BamHi-a rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC.
Zhang J; Chen H; Weinmaster G; Hayward SD
J Virol; 2001 Mar; 75(6):2946-56. PubMed ID: 11222720
[TBL] [Abstract][Full Text] [Related]
5. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.
Hsieh JJ; Hayward SD
Science; 1995 Apr; 268(5210):560-3. PubMed ID: 7725102
[TBL] [Abstract][Full Text] [Related]
6. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex.
Hsieh JJ; Zhou S; Chen L; Young DB; Hayward SD
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):23-8. PubMed ID: 9874765
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.
Fuentes-Pananá EM; Peng R; Brewer G; Tan J; Ling PD
J Virol; 2000 Sep; 74(17):8166-75. PubMed ID: 10933728
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription.
Radkov SA; Touitou R; Brehm A; Rowe M; West M; Kouzarides T; Allday MJ
J Virol; 1999 Jul; 73(7):5688-97. PubMed ID: 10364319
[TBL] [Abstract][Full Text] [Related]
9. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
Henkel T; Ling PD; Hayward SD; Peterson MG
Science; 1994 Jul; 265(5168):92-5. PubMed ID: 8016657
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
[TBL] [Abstract][Full Text] [Related]
11. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
12. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2.
Hsieh JJ; Henkel T; Salmon P; Robey E; Peterson MG; Hayward SD
Mol Cell Biol; 1996 Mar; 16(3):952-9. PubMed ID: 8622698
[TBL] [Abstract][Full Text] [Related]
13. Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJk.
Ling PD; Hayward SD
J Virol; 1995 Mar; 69(3):1944-50. PubMed ID: 7853539
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation.
Hsieh JJ; Nofziger DE; Weinmaster G; Hayward SD
J Virol; 1997 Mar; 71(3):1938-45. PubMed ID: 9032325
[TBL] [Abstract][Full Text] [Related]
15. Skip interacts with the retinoblastoma tumor suppressor and inhibits its transcriptional repression activity.
Prathapam T; Kühne C; Banks L
Nucleic Acids Res; 2002 Dec; 30(23):5261-8. PubMed ID: 12466551
[TBL] [Abstract][Full Text] [Related]
16. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.
Farrell CJ; Lee JM; Shin EC; Cebrat M; Cole PA; Hayward SD
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4625-30. PubMed ID: 15070768
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.
Fuentes-Pananá EM; Ling PD
J Virol; 1998 Jan; 72(1):693-700. PubMed ID: 9420275
[TBL] [Abstract][Full Text] [Related]
19. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
[TBL] [Abstract][Full Text] [Related]
20. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.
Strobl LJ; Höfelmayr H; Stein C; Marschall G; Brielmeier M; Laux G; Bornkamm GW; Zimber-Strobl U
Immunobiology; 1997 Dec; 198(1-3):299-306. PubMed ID: 9442401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
